
News|Articles|April 2, 2005
- Pharmaceutical Technology-04-02-2005
- Volume 29
- Issue 4
Importance of Background Microbial Levels in the Manufacture and Testing of Sterile Products
Author(s)James P. Agalloco
The sterility testing of samples from an aseptic process may be considered an entirely separate aseptic process that is subject to the same types of adventitious contamination as the aseptic process itself.
Advertisement
Articles in this issue
almost 21 years ago
April 2005almost 21 years ago
Management Controls for GMP Compliancealmost 21 years ago
The Sector Chart: A New Engineering Graph for Pharmaceutical Processesalmost 21 years ago
PAT and Process Understanding: A Call to Armsalmost 21 years ago
Cold Chain Concernsalmost 21 years ago
Evolutions in Direct Compressionalmost 21 years ago
X-ray Microtomography of Solid Dosage Formsalmost 21 years ago
Orient ExpressNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
4
Behind the Headlines Episode 31: Optimism, Opportunity, Optimization of COGs & Organizational Streamlining
5




